arrow
J

Jennifer A. Kanakry

national institutes of health
H指数:29
被引数:4,294

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Membranous Conjunctivitis in Acute and Chronic Graft-Versus-Host Disease: Longitudinal Ocular Outcomes

膜性结膜炎在急性与慢性移植物抗宿主病中的纵向眼部结局

2026-10-220
OA
Allogeneic hematopoietic cell transplantation in mature T- or NK-lymphomas: a phase II clinical trial

成熟T或NK淋巴瘤的同种异体造血细胞移植: II期临床试验

2026-04-230
OAAI
Haploidentical versus matched unrelated donor transplantation with post-transplant cyclophosphamide: a platform-dependent machine learning analysis of donor age

单倍型与匹配无关供者移植联合移植后环磷酰胺:基于平台的机器学习分析供者年龄

Leukemia
IF13.4
2026-04-150
OAAI
It mite not be graft-versus-host disease: frequency and clinical features of Demodex folliculitis after allogeneic hematopoietic cell transplantation

这可能不是移植物抗宿主病:异基因造血细胞移植后蠕形螨毛囊炎的频率和临床特征

2026-04-150
OAAI
CXCL9 as a novel prognostic marker to identify high-risk adults with hemophagocytic lymphohistiocytosis

CXCL9作为一种新型预后标志物,用于识别患有噬血细胞性淋巴组织细胞增多症的成人高风险群体。

Blood
IF23.1
2026-02-263
PRE
Usefulness and Limitations of Polymerase Chain Reaction (PCR) for the Diagnosis and Management of Toxoplasmosis Following Allogeneic Hematopoietic Cell Transplant: Single-center Experience With 31 Patients Over 16 Years

聚合酶链式反应(PCR)在异基因造血细胞移植后弓形虫病诊断与管理中的有效性与局限性:单中心16年经验,涉及31例患者

2025-08-050
OAAI
Restoration of the human skin microbiome following immune recovery after hematopoietic stem cell transplantation

造血干细胞移植后免疫恢复期间人体皮肤微生物组的恢复

2025-07-280
OAAI
Allogeneic hematopoietic stem cell transplantation for STAT3 hyper-IgE syndrome: a worldwide study

异基因造血干细胞移植治疗STAT3高IgE综合征:一项全球性研究

2025-06-230
OAAI
Choosing Between HLA-Mismatched Unrelated and Haploidentical Donors: Donor Age Considerations

选择HLA错配无亲缘关系供体与单倍型相同供体:供体年龄的考量

2025-05-240
PRE
Role of Donor Cytomegalovirus Serostatus in Cytomegalovirus-Seronegative Recipients of Unrelated Donor Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide Prophylaxis

供者巨细胞病毒血清学状态在采用异基因供者造血细胞移植并接受术后环磷酰胺预防的巨细胞病毒血清学阴性受者中的作用

2025-05-140
PRE
Impact of Donor Age and Donor Cytomegalovirus Serostatus on Outcomes After Related Donor Allogeneic Hematopoietic Stem Cell Transplantation

供者年龄和供者巨细胞病毒血清状态对亲属供者异基因造血干细胞移植后结局的影响

2025-03-120
PRE
Understanding Barriers to Hematopoietic Cell Transplant (HCT) Access: Socio-Demographic Characteristics and Area Deprivation Index (ADI) of Patients Referred to the National Institutes of Health (NIH) for HCT

理解造血细胞移植(HCT)准入的障碍:转诊至美国国立卫生研究院(NIH)进行HCT的患者的社会经济特征及区域剥夺指数(ADI)

BLOOD
IF23.1
2024-11-050
PRE
Separating the Wheat From the Chaff in Asthma and Bronchiectasis: The Saga Trajectory of a Patient With Adult-Onset RAG1 Deficiency
2023-06-011
PRE
Characterization of Hepatic Dysfunction in Subjects Diagnosed With Chronic GVHD by NIH Consensus Criteria
2022-11-015
OAAI
Abnormal liver tests are not sufficient for diagnosis of hepatic graft-versus-host disease in critically ill patients

异常肝脏检查不足以诊断危重病患者的肝移植物抗宿主病

2022-05-091
OAAI